این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Public Health، جلد ۵۲، شماره ۵، صفحات ۸۷۰-۸۷۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Phosphodiesterase-5 Inhibitors as Therapeutics for Cardiovascular Diseases: A Brief Review
چکیده انگلیسی مقاله Background: Three selective and most used inhibitors of PDE-5- sildenafil, vardenafil and tadalafil- have been successfully used for the treatment of erectile dysfunction. Erectile dysfunction and cardiovascular diseases might be considered as two dissimilar clinical signs of the identical systemic disease. PDE-5 inhibitors can through different models and mechanisms induce vasodilation, decrease apoptosis and cell proliferation, and they are widely present in various tissues that make them promising targets in a range of cardiovascular diseases. Methods: PubMed was explored to identify papers published from 1990-2019, presenting data for the most used PDE-5 inhibitors (sildenafil, tadalafil or vardenafil) in treatment of cardiovascular diseases. Results: This article analyses the therapeutic potentials of PDE-5 inhibitors in cardiovascular diseases and discusses mechanisms, possible risks and limitations. Comparable to earlier studies, newer studies suggest cardioprotective effects of PDE-5 inhibitors, which include different models and mechanisms and do not indicate an increased rate of significant cardiovascular adverse reactions. Dissimilarity in the pharmacokinetics and pharmacodynamics of PDE-5 inhibitors are significant to their risk- benefit profile and clinical use. Some of the studies suggesting infarct size reduction after PDE-5 inhibition described the especially close dose-effect relation, other studies dosage adaptation in drug- drug interactions. Conclusion: PDE-5 inhibitors indicate the encouraging useful effects by ischemia/reperfusion injury, myocardial infarction, cardiac hypertrophy, cardiomyopathy and systolic and diastolic congestive heart failure. Therefore, this and similar reviews can help for additional clinical targeting in the therapy of cardiovascular diseases.  
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Milena Corbic
Department of Neurology, Agnes Karll Laatzen Hospital, Laatzen, Germany


| Jasmina Sretenovic
Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia


| Vladimir Zivkovic
1. Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia 2. Department of Pharmacology, First Moscow State Medical University, University I.M. Sechenov, Moscow, Russia


| Vladimir Jakovljevic
1. Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia 2. Department of Human Pathology, First Moscow State Medical University, University I.M. Sechenov, Moscow, Russia


| Tamara Nikolic Turnic
1. Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia 2. Department of Public Health and Healthcare N. A. Semashko, F.F. Erismann Institute of Public Health, First Moscow State Medical University, University I.M. Sechenov, Moscow, Russia
نشانی اینترنتی https://ijph.tums.ac.ir/index.php/ijph/article/view/27461
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات